Assessment of the quality of pharmacoeconomic evaluation literature in China

References

• CPC Central Committee and State Council on Deepening the Health Care Reform [ED/OL]. Xinhua News Agency. Retrieved April 8 2009. 2009. http://www.gov.cn/test/2009-04/08/content_1280069.htm
   Google Scholar
• Chinese Pharmacoeconomics Evaluation Guide Research Group, Liu GE, Hu SH, Wu JH. Chinese pharmacoeconomics evaluation guide (2011 edition). Chin Pharmacoeconom 2011;3:1-23
   Google Scholar
• Chang YP, Xie YM. Overview of pharmacoeconomic research on traditional Chinese and Western treatment of stroke. J Chin Med Mater 2012;37:3509-12
   Google Scholar
• Chen X, Zhai SD. Clinical efficacy and pharmacoeconomics of human insulin: weight at both ends of the balance. Drug Evaluat 2012;9:6-9
   Google Scholar
• Zhu HF, Long JL, Sun L, et al. Pharmacoeconomic evaluation of different nifedipine formulations for treating hypertension. Chin Pharmacoeconom 2013;3:33-5
   Google Scholar
• Jiang Y, Liu Li, Zhang BH. Analysing clinical usage of rheumatoid arthritis drug. Modern Prevent Med 2013;40:3891-3
   Google Scholar
• He JJ, Li YM, Zhuang Y, et al. Pharmacoeconomic evaluation of somatostatin analogues before acromegaly surgery. Chin Health Ins 2014;2:52-6
   Google Scholar
• Xu F, Liu GE, Tang Y, et al. Pharmacoeconomic evaluation of Qizheng plaster in treatment on acute lumbar sprain. Chin Pharmacoeconom 2014;8:9-13
   Google Scholar
• Zhu L, Liu GE, Li DM, et al. Cost-effectiveness analysis of pediatric seven-valent pneumococcal conjugate vaccine. Chin Health Econ 2013;32:71-5
   Google Scholar
• Zhou HY. Cost-effectiveness analysis of 3 regimens in treatment of patients with decompensated hepatitis B. Chin J New Drugs 2012;21:654-7
   Google Scholar
• Zhou L, Huang LH. Cost-effectiveness analysis of 4 regimens in patients with decompensated hepatitis B. J Chin Hosp Pharm 2012;32:1306-9
   Google Scholar
• Lao GQ, Wang JL, Wu Y. Cost-effectiveness analysis of 4 nucleoside analogs in treatment of chronic hepatitis B. Herald Med 2012;31:435-7
   Google Scholar
• Ma YH, Xu YF, Niu HL. Pharmacoeconomic evaluation of 4 antibiotics in treatment of chronic obstructive pulmonary disease complicated with pulmonary infection. Gansu Med J 2012;31:333-6
   Google Scholar
• Zhang XH, Zhao P, Zhang XL, et al. Pharmacoeconomic evaluation of domestic and imported cefuroxime sodium in the treatment of bacterial infections. J Chin Antibiot 2012;37:145-8, 162
   Google Scholar
• Chen JQ, Yin YZ, Yang R, et al. Pharmacoeconomic analysis of two chemotherapeutic regimens in treatment of advanced gastric cancer. Mod Hosp 2012;12:52-3
   Google Scholar
• Chen XJ, Xia ZH, Zhang MZ, et al. Cost-effectiveness analysis of four chemotherapy intravesical instillation in prevention of superficial bladder cancer through the urethra resection of bladder tumor recurrence. Chin Gen Prac 2012;15:2188-90
   Google Scholar
• Lin GX, Lin HL, Lu XH. Cost-effectiveness analysis of 3 dosing regimens in treating early Parkinson’s disease. Pharm Today 2013;3:142-4
   Google Scholar
• Li YQ. Cost-effectiveness analysis of 3 drugs in treating osteoporosis. J Pharm Prac 2013;2:143-4, 150
   Google Scholar
• Wang JC, Yang DK, Zheng JH, et al. Economic evaluation of 4 anti-virus programs in treating chronic hepatitis B. Chin Pharm 2013;18:1633-5
   Google Scholar
• Kang Q, Yu Z. Pharmacoeconomic evaluation of EGFR-TKI in patients with advanced non-small cell lung cancer. Chin Drug Eval 2013;5:305-8
   Google Scholar
• Deng CY, Wang YZ, Liu X, et al. Cost-effectiveness analysis of 4 interventions in treating hypertension in the workplace. Chin J Hypertens 2013;2:148-53
   Google Scholar
• Chen XY, Wang XR, Dong GL, et al. Clinical evaluation and pharmacoeconomic analysis of two regimens in treating metastatic breast cancer. Chin J Clin Oncol 2013;19:1160-4
   Google Scholar
• Fu YN, Liu GE, Zhu L, et al. Cost-effectiveness analysis of heptad pneumococcal conjugate vaccine against pneumococcal disease. Chin Health Econ 2013;1:49-52
   Google Scholar
• Zhuang QZ. Pharmacoeconomic evaluation of entecavir and recombinant human interferon a-2b in treating chronic hepatitis. Herald Med 2014;4:456-8
   Google Scholar
• Chen GW. Efficiency and safety analysis of common PPI drugs in treating reflux esophagitis. Chin Pharm Guide 2014;17:223-4
   Google Scholar
• Min TS, Sui WP, Liu J. Cost- effectiveness analysis of entecavir and adefovir in treating chronic hepatitis B. Chin J Hosp Pharm 2014;34:1499-501
   Google Scholar
• Wang GL, He Y, Wang X, et al. Cost-effectiveness analysis of Interferon α-2b and pegylated interferon α-2a in treating chronic hepatitis C. Modern West Med 2014;23:919-20, 944
   Google Scholar
• Chen LH, Huang WZ. Cost-effectiveness analysis of two PPIs in treating Helicobacter pylori positive duodenal ulcer. Chin Pharm Guide 2013;11:429-30
   Google Scholar
• Wu JW, Zhang YF. Cost-effectiveness analysis of two antibacterial drugs in treating urinary tract infections. Chongqing Med J 2013;42:1395-7
   Google Scholar
• Zhao LR. Cost-effectiveness analysis of three clinical regimens for community acquired pneumonia in elderly patients with chronic obstructive pulmonary disease. Chin Med 2013;10:122-4
   Google Scholar
• Tan H, Yuan HY, Ji P. Economic evaluation of calcium citrate drug to treat osteoporosis. Modern Med Health 2014;30:2266-7
   Google Scholar
• Zhang JH. Cost-effectiveness evaluation of losartan and benazepril in treatment of mild to moderate hypertension. Chin Pharmacoeconom 2014;3:9-11
   Google Scholar
• Wang L, Zhou LM. Minimum cost analysis of two different dosage form of acarbose in treatment with type 2 diabetes. Drug Eval 2014;1:32-5
   Google Scholar
• Xiao J. Economic evaluation of two proton pump inhibitor in treatment with helicobacter pylori infection gastric ulcer with activity. Hebei Med J 2014;20:413-15
   Google Scholar
• Fu YZ, Xu WH, Wei SH. Pharmacoeconomic study of Yinxingdamo and Salvia ligustrazine injection in adjuvant treatment of elderly patients with acute cerebral infarction. Chin Pharm Clin 2014;14:77-9
   Google Scholar
• Liu M, Zhang SC, Min J, et al. Pharmacoeconomic analysis of hospitals and community health service centers combined intervention model in patients with coronary heart disease after revascularization. Chin J Hosp Pharm 2013;33:1634-8
   Google Scholar
• Zhu JJ, Chen W. Pharmacoeconomics of vildagliptin in combination with metformin in treatment of diabetes. Chin Pharmacoeconom 2013;4:11-16
   Google Scholar
• Wu JY, Zhang FZ, Zhang FR, et al. The efficacy and cost study of Black Lands Yellow Pills in treatment of chronic renal failure. Shandong Chin Med 2014;1:23-5
   Google Scholar
• Yu ZH, Wang XR, Wang Y. Cost-effectiveness analysis of amoxicillin and moxifloxacin in treatment of senile bronchitis. Jilin Med J 2012;33:3455-6
   Google Scholar
• Zhang H. Pharmacoeconomic evaluation of two schemes of Azithromycin in treatment of lower respiratory infections. West Med 2012;24:772-3
   Google Scholar
• Pang XM, Song YH, Xu XB. Pharmacoeconomic analysis of two hypertension treatment regimens. Chin Pharm Guide 2012;10:163-4
   Google Scholar
• Yang QW, Li GD. Clinical efficacy and pharmacoeconomic evaluation of 2 inhaled therapies in treatment of patients with severe COPD. Taishan Med Coll 2012;33:363-5
   Google Scholar
• Wang Z, Jin XY. Effective analysis of different treatment schemes of severe COPD with pseudomonas aeruginosa infection. J Clin Pulmon Med 2013;18:2017-19
   Google Scholar
• Wang NQ, Wang SQ, Diao Y. Pharmacoeconomic analysis of Danshen tablets and compound Danshen dripping pills in treatment of coronary heart disease. Strait Pharm J 2013;25:212-14
   Google Scholar
• Wang WQ. Pharmacoeconomic evaluation of domestic azithromycin in treatment of pediatric infectious diseases. Chin Modern Doctor 2013;51:27-8, 31
   Google Scholar
• Li XF, Chen Y. The analysis of import and domestic pemetrexed disodium in treatment of non-small cell lung cancer. J Clin Pulmon Med 2013;18:1098-100
   Google Scholar
• Shang JH. Clinical application experience and analysis of anti-hypertensive drug in 320 cases of patients. Chin J Prac Med 2013;8:194-5
   Google Scholar
• Zheng B. Economic assessment of risperidone and clozapine in treatment of schizophrenia. Strait Pharm J 2014,26:135-6
   Google Scholar
• Shi YF, Yan H, Sun SG, et al. Systematic evaluation and pharmacoeconomic analysis of two Salvia injections in treating Coronary Angina Pectoris. Chin J Evidence-Based Med 2014;14:287-91
   Google Scholar
• Wang YH, Yu CY, Zhang J, et al. Pharmacoeconomic evaluation of 2 schemes in treatment of acute ischemic cerebrovascular disease. Chin J Biochem Pharm 2014;1:135-7
   Google Scholar
• Li L. Clinical efficacy and pharmacoeconomics of Qingzhi Powder in the treatment of hyperlipidemia. Chin J Prac Med 2014;14:179-80
   Google Scholar
• Luo XZ, Mo XX. Cost-effectiveness analysis of cefprozil and cefaclor in treatment of children upper respiratory tract infections. Chin Pharmacoeconom 2014;7:9-10
   Google Scholar
• Huo Y. Efficacy and economics between imipenem cilastatin sodium and moxifloxacin in treatment of severe community-acquired pneumonia. Chin J Prac Med 2014;19:152-3
   Google Scholar
• Zhang HJ, Zhang FP. Economic analysis of 4 calcium channel blockers commonly used in treating of hypertension. Chin J Integrat Med Cardio-/Cerebrovasc Dis 2014;12:695-6
   Google Scholar
• Liu YQ, Peng B, Li QF, et al. Cost-effectiveness analysis of three regimens in treatment of type 2 diabetes. Chongqing Med J 2014;43:2470-3
   Google Scholar
• Yan TS, Sun WP, Liu J. Cost-effectiveness analysis of entecavir and adefovir in treatment of chronic hepatitis B. Chin J Hosp Pharm 2014;34:1499-501
   Google Scholar
• Zhang YM. Cost-effectiveness analysis of Pule'an and finasteride in treatment of benign prostatic hyperplasia. Gansu J Trad Chin Med 2013;32:850-1
   Google Scholar
• Wang YY, Dou LP, Zhong Y. Cost-effectiveness analysis of Chinese medicine combined with chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer. Shandong J Trad Chin Med 2013;53:18-21
   Google Scholar
• Song JW, Li CB, Song YX, et al. Economic evaluation and the clinical effect of traditional Chinese medicine injections assisted PD in treatment of advanced ovarian cancer. Mod Oncol 2013;21:2796-8
   Google Scholar
• Shi F, Xie BQ, Shu Q. Cost-effectiveness analysis of five antibiotics for patients with urinary tract infections. Anti-infect Pharm 2014;11:231-3, 243
   Google Scholar
• Xu YY, Cai XJ, Zhang XC, et al. Pharmacoeconomics of 3 anti-coronary drugs in the treatment of angina pectoris. Strait Pharm J 2013;25:197-8
   Google Scholar
• Qiu DQ. Cost-effectiveness analysis of 4 treatment regimens of community II diabetes. Chin J Public Health Manage 2013;29:238-9
   Google Scholar
• Jiang YM, Yang XY. Pharmacoeconomic analysis of four topical treatments of oral ulcers. J Med Theory Prac 2013;26:820-1
   Google Scholar
• Wu YH, Huang JP. Cost-effectiveness analysis of 2 controlled intravenous analgesia regimens in geriatric patients. Pharm Today 2014;6:406-8
   Google Scholar
• Ding GH, Zhang Q, Feng B, et al. Cost-effectiveness analysis of 3 drugs for treating cerebrovascular disease brain dysfunction. Aerospace Med 2014;25:1001-2
   Google Scholar
• Wang YH, Yu CY, Zhang J, et al. Clinical observation of Ozagrel and Naodesheng in sequential treatment of acute cerebral infarction. Chin Pharm 2014;25:699-701
   Google Scholar
• Xue X, Gao JR, Xia LZ, et al. Cost-effectiveness analysis of glimepiride in combination with different drugs in treatment of type 2 diabetes. Anhui Med J 2014;18:441-3
   Google Scholar
• Chen SY, Cen YH. Economic evaluation of our hospital’s 2 treatment regimens of acute ankle sprain. Neimenggu Trad Chin Med 2014;33:154-5
   Google Scholar
• Wang HX. Cost-effectiveness analysis of 5 commonly used drugs in treatment of acute cerebral infarction. Chin Modern Drug Applic 2014;8:147-8
   Google Scholar
• Pan MY. Efficacy and economic analysis opioid receptor antagonist in treatment of severe traumatic brain injury. Strait Pharm J 2013;25:272-4
   Google Scholar
• Wang QH, He Y, Wang YH. Economic evaluation of randomized controlled trial of moxifloxacin and levofloxacin injection in treatment of community acquired pneumonia. Chin Pharmacoeconom 2013;3:36-9
   Google Scholar
• Yan XY, Li Z, Yu Q, et al. Cost-effectiveness analysis of 3 drug treatments of senile chronic functional constipation. Chin J New Drugs Clin Remedies 2013;32:154-7
   Google Scholar
• Lin LQ, Yang YY, Lin Y. Pharmacoeconomics of two treatments of acute obstructive pulmonary disease. Strait Pharm J 2014;26:179-82
   Google Scholar
• Xu CJ, Jiang TF, Sun Yi. Cost-minimization analysis of two chemotherapy regimens in treatment of non-small cell lung cancer. Chin J Clin Pharm 2014;23:35-8
   Google Scholar
• Tan B, Wu F, Wang Y. The effectiveness and economic evaluation of different injections of traditional Chinese medicine in auxiliary treatment of liver cancer. Evaluat Anal Drug-use Hosp China 2013;13:494-6
   Google Scholar
• Li YJ. Cost minimization analysis of two meropenem infusion regimens in treatment of ventilator-associated pneumonia. Chin J Modern Drug Applic 2013;14:121-2
   Google Scholar
• Qu LY, Zhang W, Cai S, et al. Cost-effectiveness analysis of Rina thiazole amine with vancomycin in the treatment of methicillin-resistant staphylococcal pulmonary infection. Chin J New Drugs Clin Remed 2013;32:578-81
   Google Scholar
• Liu M, Zhang SC, Xu YN, et al. Pharmacoeconomic analysis of combined management by hospital and community health service center of patients post coronary revascularization. Chin J Hosp Pharm 2013;12:1634-8
   Google Scholar
• Zhang BS, Shen WX, Wang H, et al. Cost-effectiveness analysis of 4 types of treatments in patients with type 2 diabetes in community. J Ning Xia Med Uni 2013;35:906-9
   Google Scholar
• Zhou FJ, Kuang XH. Comparison of the cost-effectiveness in two preventive treatments of postoperative infection of acute appendicitis. Chin Modern Med 2013;30:134-5
   Google Scholar
• Xu CJ, Jiang YF, Sun Y. Cost minimization analysis of two regimens in treatment of non-small cell lung cancer. Chin J Clin Pharm 2014;23:35-8
   Google Scholar
• Hou XY, Tao X, Zhang C, et al. Cost-effectiveness analysis of two metformin hydrochloride formulations in the treatment of type 2 diabetes. Chin Pharm 2014;25:1844-7
   Google Scholar
• Wu X, Chi C, Kou JG, et al. Cost-effectiveness analysis of rabeprazole and esomeprazole in treatment of reflux esophagitis. J Modern Med 2010;30:143-4
   Google Scholar
• Yang Z, Liu XH, Liu SK, et al. Cost-effectiveness analysis of 2 schemes in treating bacterial infections in acute exacerbation of severe COPD. Chin Pharm 2012;23:356-8
   Google Scholar
• Du H, Yang Z, Ge LH, et al. Cost-effectiveness analysis of 3 different regimens drug-induced liver injury in patients infected with HIV/TB using antituberculosis drugs. Chin Pharm 2012;23:3803-6
   Google Scholar
• Fang H. Pharmacoeconomic analysis of 3 antihypertensive drugs in treatment of hypertension. Strait Pharm J 2012;24:267-9
   Google Scholar
• Zhou YY. Cost-minimization analysis of 3 selective 5-HT reuptake inhibitors in treatment of somatoform disorders. Chin J Clin Pharm 2012;21:318-20
   Google Scholar
• Dong JY, Cui CL, Tao ZM, et al. Cost-minimization analysis of moxifloxacin sequential therapy of community-acquired pneumonia. Chin Pharm 2012;21:36-7
   Google Scholar
• Zhao K, Yang HT, Chang C. Cost-effectiveness analysis of 3 proton pump inhibitors combined with flupentixol melitracen in treatment of functional dyspepsia. Chin Pharmacoeconom 2013;6:9-10, 18
   Google Scholar
• Li YJ. The minimum cost analysis of two different meropenem infusion schemes in treating ventilator-associated pneumonia. Chin J Mod Drug Applic 2013;7:121-2
   Google Scholar
• Bi YZ, Zeng DX, Sheng GF, et al. Cost-effectiveness analysis of 3 antiemetic programs in treating of cisplatin-induced vomiting. J Basic Clin Oncol 2012;25:414-7
   Google Scholar
• Yu F, Pu R, Cui YM, et al. Cost-effectiveness analysis of pirarubicin and epirubicin in neoadjuvant chemotherapy of breast cancer. Chin Pharm 2012;23:347-50
   Google Scholar
• Xu XG, Zou LX. Pharmacoeconomic analysis of domestic and imported entecavir treatment of viral hepatitis B. Strait Pharm J 2012;24:247-8
   Google Scholar
• Liang XL, Yan XQi. Pharmacoeconomics of gemcitabine combined with different platinum in treatment of advanced non-small cell lung cancer. Med Innovat Chin 2012;9:155-6
   Google Scholar
• Zheng YG, An AJ, Cao JJ, et al. Cost-effectiveness analysis of 3 second-line schemes in treating of non-small cell lung cancer. Med Innovat Chin 2012;9:149-50
   Google Scholar
• Zhao F. The effect of patients with breast hyperplasia selecting different treatment programs in the guidance of pharmacoeconomics. Chin Health Ind 2012;9:101
   Google Scholar
• Xue L, Yang W. Pharmacoeconomic evaluation of different formulations of metformin in treatment of type 2 diabetes complicated with lung cancer. Pharm Care Res 2012;12:438-41
   Google Scholar
• Ma CL. Cost-effectiveness analysis and adverse reactions of Azithromycin and clarithromycin in treatment of Helicobacter pylori-induced peptic ulcer. Qinghai Med J 2013;6:71-2
   Google Scholar
• Jiang LH, Chen CY, Huo CF. Pharmacoeconomic analysis of six oral hypoglycemicregimens in National essential drug lists. Chin J Drug Applic Monit 2013;10:131-4
   Google Scholar
• Li ZQ, He X. Cost-effectiveness analysis of 3 prevention infection programs after cesarean section in a certain hospital. Drug Evaluat 2013;10:23-6
   Google Scholar
• Wang CX, Wang HY. Cost-effectiveness analysis of 3 treatment programs of advanced non-small cell lung cancer. Chin Health Ind 2013;10:152-3
   Google Scholar
• Zhong SY. Cost-effectiveness analysis of sitagliptin and pioglitazone associated with metformin respectively in type 2 diabetes. Chin Pharmacoeconom 2013;4:19-20
   Google Scholar
• Yu L, Feng SL, Jia XF. Cost-effectiveness analysis of sodium hyaluronate in treatment of knee osteoarthritis. Chin Pharm 2013;24:2265-7
   Google Scholar
• Hong HJ. Pharmacoeconomic analysis of fleroxacin sequential therapy of urinary tract infections. Chin Pharmacoeconom 2013;3:21-2
   Google Scholar
• Xu HY, Han XM, Huang JP. Cost-effectiveness analysis of Chinese and Western medicine in treatment of respiratory syncytial viral pneumonia in children. Liaoning J Tradit Med 2013;40:1188-9
   Google Scholar
• Wang ZL, Li X. Cost-effectiveness analysis of 3 sulfonylurea drugs for initial treatment of type 2 diabetes. Chin Pharm 2014;25:2019-21
   Google Scholar
• Zhao P, Zhang XH, Meng L. Cost-effectiveness analysis of 2 traditional Chinese medicine injections in treatment of diabetic peripheral neuropathy. Pharm Clin Res 2014;22:368-70
   Google Scholar
• Chen X, Xu YJ, Li Y, et al. Pharmacoeconomic evaluation of dosing regimens of imipenem anti postoperative infection combining Monte Carlo simulation. Chin J New Drugs 2013;22:691-4, 708
   Google Scholar
• Cai L. Pharmacoeconomic analysis of 4 treatments in elderly hypertensive. Chin Pract Med 2014;10:32-3
   Google Scholar
• Ding XY, Zhang GY, Li CL, et al. Pharmacoeconomics analysis of antimicrobial treatment of children with bronchial pneumonia. J Pediat Pharm 2014;20:36-40
   Google Scholar
• Zhang LF, Xu L. Cost-effectiveness analysis of 2 community-acquired pneumonia treatments. J Pharm Prac 2014;32:315-17
   Google Scholar
• Zhang BS, Shen WX, Wang H, et al. Cost-effectiveness analysis of 4 treatment regimens of Type 2 diabetes in the community. J Ningxia Med Uni 2013;35:906-9
   Google Scholar
• Chen SF. Cost-effectiveness analysis of import and domestic teicoplanin in treatment of lower respiratory tract infections. Strait Pharm J 2013;25:199-201
   Google Scholar
• Sun YF. Pharmacoeconomic analysis of different methods of anesthesia in children with colic. J Med Res 2013;42:143-6
   Google Scholar
• Li MH, Ma AX. Current status, problems and suggestions of drug economic evaluation in China. Chin Pharm 2008;11:801-5
   Google Scholar